Back to Search
LYDIA USHA, M.D.
M.D.
Medical Oncology Physician
NPI: 1336109693IndividualAccepts Medicare
Education
OTHER
Class of 1982
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (3)
Topoisomerase II alpha gene copy loss has adverse prognostic significance in ERBB2-amplified breast cancer: a retrospective study of paraffin-embedded tumor specimens and medical charts.
PMID 18702822·J Hematol Oncol·2008
8-other
CD5+ immunophenotype in the bone marrow but not in the peripheral blood in a patient with hairy cell leukemia.
PMID 11014896·Acta Haematol·2000
5-case
Effects of ERBB2 amplicon size and genomic alterations of chromosomes 1, 3, and 10 on patient response to trastuzumab in metastatic breast cancer.
PMID 17243161·Genes Chromosomes Cancer·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 1725 W HARRISON ST, SUITE 1010
CHICAGO, IL 60612 - Phone
- (312) 942-5904
Quick Facts
- NPI
- 1336109693
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 44
- Clinical Trials
- 1
- Publications
- 3
Are you this provider?
Claim Your Profile